EVERENCE CAPITAL MANAGEMENT INC - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
EVERENCE CAPITAL MANAGEMENT INC ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$398
-35.8%
13,510
-17.9%
0.03%
-38.0%
Q2 2023$620
+7.1%
16,4500.0%0.05%
+6.4%
Q1 2023$579
-23.2%
16,4500.0%0.05%
-27.7%
Q4 2022$754
-99.9%
16,4500.0%0.06%
-12.2%
Q3 2022$797,000
+23.4%
16,4500.0%0.07%
+27.6%
Q2 2022$646,000
+26.2%
16,450
+18.3%
0.06%
+48.7%
Q1 2022$512,000
-19.2%
13,9000.0%0.04%
-17.0%
Q4 2021$634,000
+27.6%
13,9000.0%0.05%
+14.6%
Q3 2021$497,000
+146.0%
13,900
+36.3%
0.04%
+141.2%
Q2 2021$202,000
-14.8%
10,2000.0%0.02%
-22.7%
Q1 2021$237,000
-23.5%
10,200
-31.6%
0.02%
-26.7%
Q4 2020$310,000
-4.0%
14,9100.0%0.03%
-16.7%
Q3 2020$323,000
-4.7%
14,910
-9.0%
0.04%
-10.0%
Q2 2020$339,000
+75.6%
16,3800.0%0.04%
+48.1%
Q1 2020$193,000
+10.9%
16,3800.0%0.03%
+3.8%
Q4 2019$174,000
-6.5%
16,3800.0%0.03%
-13.3%
Q3 2019$186,000
+1.1%
16,3800.0%0.03%0.0%
Q2 2019$184,000
+38.3%
16,3800.0%0.03%
+30.4%
Q1 2019$133,00016,3800.02%
Other shareholders
CYTOKINETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders